Journal of Diabetes Research / 2020 / Article / Tab 1 / Review Article
Prevalence of Diabetic Nephropathy among Patients with Type 2 Diabetes Mellitus in China: A Meta-Analysis of Observational Studies Table 1 Summarized information of studies included in meta-analysis.
First author (publication year) Survey date Diagnosis standards for DN Diagnosis standards for DM Area Population source Age (years) BMI Sex (%males) Course of DM (years) Systolic blood pressure Diastolic blood pressure Sample size Quality score Song (2014) [12 ] 2012 Clinical diagnosis Clinical diagnosis Shanghai Community-based <59 25 55.7 NA NA NA 436 12 Xu (2012) [13 ] 2008-2009 KDOQI 2007 ADA criteria 2005 Shanghai Community-based NA 40.8 NA NA 1421 22 Ke (2013) [14 ] 2011 Mogensen criteria WHO criteria 1999 Huangshi, Hubei Community-based NA NA 53.1 NA NA NA 918 20 Guo (2006) [15 ] 2002 Clinical diagnosis WHO criteria 1999 Beijing Hospital-based NA 60 NA NA NA 402 22 Mou (2010) [16 ] 2003-2008 Renal biopsy History of DM Shanghai Hospital-based NA 52.2 NA 69 22 Kung (2014) [17 ] 2009-2011 Clinical diagnosis Clinical diagnosis Hong Kong Hospital-based 60(20-) 25 48.8 15856 22 Zhou (2012) [18 ] 2003-2010 Clinical diagnosis WHO criteria 1999 Beijing Hospital-based 25 56.8 NA NA 1758 21 Qu (2003) [19 ] 1994-2001 Mogensen criteria 1985 WHO/1999 China criteria Changsha, Hunan Hospital-based NA 47.4 NA NA 1718 17 Teng (2001) [20 ] 1997-2000 Clinical diagnosis WHO criteria 1985 Shanghai Hospital-based >43 NA NA NA NA NA 1059 22 Xing (2009) [21 ] 2007-2009 Clinical diagnosis WHO criteria 1999 Benxi, Liaoning Hospital-based NA 51.2 NA NA 2276 22 Lu (2002) [22 ] 1996-2001 Clinical diagnosis Clinical diagnosis Suzhou, Jiangsu Hospital-based >45 NA NA NA NA 821 21 Liu (2010) [23 ] 2003-2006 Renal biopsy Clinical diagnosis Shanghai Hospital-based NA 56.5 6 NA NA 46 21 Zou (2000) [24 ] 1993-1998 Clinical diagnosis WHO criteria 1985 Beijing Hospital-based NA 62.8 NA NA 1217 20 Tang (2005) [25 ] NA Clinical diagnosis History of DM Panzhihua, Sichuan Hospital-based 17-83 NA 52.5 0-20 NA NA 324 18 Yu (2006) [26 ] 1991-2000 Clinical diagnosis History of DM Hangzhou, Zhejiang Hospital-based NA 49.3 NA NA 874 19 Wang (2014) [27 ] 2013 Clinical diagnosis History of DM Fushun, Liaoning Hospital-based 45.1 NA NA 750 20 Chen (2007) [28 ] 2005 ADA criteria 1997 Clinical diagnosis Shanghai Hospital-based 48.1 408 20 Yu (2012) [29 ] 2011 Clinical diagnosis WHO criteria 1999 Shanghai Community-based 40.5 NA 516 21 Xu (2016) [30 ] 2014-2015 CTM criteria 2010 WHO criteria 2004 Linyi, Shandong Hospital-based NA NA NA NA NA 500 19 Zhang (2016) [31 ] 2011 ADA criteria 2007 WHO criteria 1999 Dalian, Liaoning Hospital-based 61.5 25.7 NA NA 152.9 83.23 2345 20 Li (2014)-1 [32 ] 2009 Clinical diagnosis Clinical diagnosis Tongxiang, Zhejiang Hospital-based >60 NA 57.7 NA NA NA 302 20 Li (2014)-2 [32 ] 2012 Clinical diagnosis Clinical diagnosis Tongxiang, Zhejiang Hospital-based >60 NA 57.7 NA NA NA 494 20 Zeng (2014) [33 ] 2010-2013 Clinical diagnosis ADA criteria 2009 Guangzhou, Guangdong Hospital-based NA 56.7 1~24 NA NA 842 21 Hu (2016) [34 ] 2011-2012 Clinical diagnosis WHO criteria 1999 Guangdong Hospital-based NA 48.8 NA NA NA 4101 23 Wang (2017) [35 ] 2014-2015 KDOQI 2014 History of DM Lanzhou, Gansu Hospital-based NA 58.6 NA NA 558 21 Guo (2016) [36 ] 2005-2012 KDOQI 2012 WHO criteria 1999 Shanghai Hospital-based 55.1 8.48 3301 22 Zhuo (2013) [37 ] 2003-2011 Renal biopsy ADA criteria 2007 Beijing Hospital-based 28-64 NA 61.9 2-20 NA NA 244 22 Yang (2018) [38 ] 2014-2017 KDIGO guidelines 2012 History of DM Hong Kong Hospital-based NA 50.4 31574 26 Duan (2019) [39 ] 2015-2017 Clinical diagnosis The American Diabetes Association (ADA) 2009 Henan Community-based 40.2 NA NA NA 2710 26 Liu (2010) [40 ] 2007 Clinical diagnosis Clinical diagnosis Multicenter (Shanghai, Chengdu, Beijing and Guangzhou) Hospital-based NA 41.8 8.7 NA NA 1524 26
Abbreviations: NA: not available; KDIGO: Kidney Disease Improving Global Outcomes; ADA: American Dental Association; KDOQI: Kidney Disease Outcomes Quality Initiative; CTM: Chinese Traditional Chinese Medicine Association.
Quality score of STROBE checklist.
